155 related articles for article (PubMed ID: 87277)
1. Combination chemotherapy for mycosis fungoides: a Southwest Oncology Group study.
Grozea PN; Jones SE; McKelvey EM; Coltman CA; Fisher R; Haskins CL
Cancer Treat Rep; 1979 Apr; 63(4):647-53. PubMed ID: 87277
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy in the tumour stage of mycosis fungoides with cyclophosphamide, vincristine, vp-16, adriamycin and prednisolone (cop, chop, cavop): a report from the Scandinavian mycosis fungoides study group.
Molin L; Thomsen K; Volden G; Groth O; Hellbe L; Holst R; Knudsen EA; Roupe G; Schmidt H
Acta Derm Venereol; 1980; 60(6):542-4. PubMed ID: 6162347
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy with bleomycin, cyclophosphamide, prednisone and etretinate (BCPE) in advanced mycosis fungoides: a six-year experience.
Zachariae H; Thestrup-Pedersen K
Acta Derm Venereol; 1987; 67(5):433-7. PubMed ID: 2448996
[TBL] [Abstract][Full Text] [Related]
4. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
5. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
[TBL] [Abstract][Full Text] [Related]
6. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
7. Oral retinoid in combination with bleomycin, cyclophosphamide, prednisone and transfer factor in mycosis fungoides.
Zachariae H; Grunnet E; Thestrup-Pedersen K; Molin L; Schmidt H; Starfelt F; Thomsen K
Acta Derm Venereol; 1982; 62(2):162-4. PubMed ID: 6179344
[TBL] [Abstract][Full Text] [Related]
8. Tumour stage of mycosis fungoides treated with bleomycin and methotrexate: report from the Scandinavian mycosis fungoides study group.
Groth O; Molin L; Thomsen K
Acta Derm Venereol; 1979; 59(1):59-63. PubMed ID: 84469
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy with cyclophosphamide, vincristine, and prednisone (CVP) in TNM-classified stage IV mycosis fungoides.
Tirelli U; Carbone A; Veronesi A; Galligioni E; Trovò MG; Tumolo S; Grigoletto E
Cancer Treat Rep; 1982 Jan; 66(1):167-9. PubMed ID: 7053252
[TBL] [Abstract][Full Text] [Related]
10. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
Sampi K; Honda T; Hattori M; Takayama S
Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology.
Canellos GP; Skarin AT; Rosenthal DS; Moloney WC; Frei E
Cancer Treat Rep; 1981; 65 Suppl 1():125-9. PubMed ID: 6173118
[TBL] [Abstract][Full Text] [Related]
12. Treatment of recurrent lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): a Southwest Oncology Group Study.
Weick JK; Jones SE; Haut A; Fisher R; Dixon D
Cancer Treat Rep; 1981; 65(7-8):611-4. PubMed ID: 6166373
[TBL] [Abstract][Full Text] [Related]
13. Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group study.
Jones SE; Grozea PN; Metz EN; Haut A; Stephens RL; Morrison FS; Butler JJ; Byrne GE; Moon TE; Fisher R; Haskins CL; Coltman CA
Cancer; 1979 Feb; 43(2):417-25. PubMed ID: 84706
[TBL] [Abstract][Full Text] [Related]
14. Systemic polychemotherapy in patients with mycosis fungoides and lymph node involvement: a follow-up study of 17 patients.
Sentis HJ; Willemze R; Van Vloten WA
Acta Derm Venereol; 1985; 65(2):179-83. PubMed ID: 2408428
[TBL] [Abstract][Full Text] [Related]
15. Advanced diffuse histiocytic lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) without maintenance therapy.
Armitage JO; Corder MP; Leimert JT; Dick FR; Elliot TE
Cancer Treat Rep; 1980; 64(4-5):649-54. PubMed ID: 7000347
[TBL] [Abstract][Full Text] [Related]
16. Advanced mycosis fungoides: chemotherapy with etoposide, methotrexate, bleomycin, and prednimustine.
Doberauer C; Ohl S
Acta Derm Venereol; 1989; 69(6):538-40. PubMed ID: 2481928
[TBL] [Abstract][Full Text] [Related]
17. Epipodophyllotoxin (VP-16-213) in mycosis fungoides: A report from the Scandinavian mycosis fungoides study group.
Molin L; Thomsen K; Volden G; Bergqvist-Karlsson A; Hallberg O; Hellbe L
Acta Derm Venereol; 1979; 59(1):84-7. PubMed ID: 84480
[TBL] [Abstract][Full Text] [Related]
18. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V
Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751
[TBL] [Abstract][Full Text] [Related]
19. European experience with ifosfamide in lymphomas.
von Kalle AK; Schaadt M; Diehl V
Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
[TBL] [Abstract][Full Text] [Related]
20. Sequential use of endocrine therapy and chemotherapy for metastatic breast cancer: effects on survival.
Manni A; Trujillo JE; Pearson OH
Cancer Treat Rep; 1980 Jan; 64(1):111-6. PubMed ID: 6155207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
